Batch: GF-BPCTB10-B241 Key analytical results include: BPC-157 Assay Content: 16.04 mg BPC-157 Identification by RT: 0.993 BPC-157 Purity: greater than 99.8 percent BPC-157 Molecular Ion Mass Identification: 1418 Da TB-500 Assay Content: 13.44 mg TB-500 Identification by RT: 0.999 TB-500 Purity: 99.6 percent TB-500 Molecular Ion Mass Identification: 4962 Da Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview BPC-157/TB-500 is a dual-peptide research formulation combining two extensively studied peptide compounds within a single laboratory preparation
AOD-9604 is a synthetic peptide fragment consisting of amino acids 176-191 from the C-terminal region of human growth hormone with a stabilizing tyrosine modification
Exercise increases IGF-1 and angiogenesis
Most patients achieve therapeutic benefits with 250-500 mcg daily, administered subcutaneously in the abdomen, thigh, or arm
| Target Concentration | BAC Water to Add | Dose per 10 units on syringe | |---------------------|-----------------|------------------------------| | 8mg/ml | 3.0ml | 0.8mg | | 12mg/ml | 2.0ml | 1.2mg | | 6mg/ml | 4.0ml | 0.6mg | **Best for:** Patients on 4-8mg weekly doses (therapeutic range)
Local focus: Familiar with Las Vegas residents' lifestyles and wellness challenges in our desert climate Las Vegas Semaglutide with B12 Program Advantages Results are backed by medical science and delivered through experienced physician supervision that ensures your safety throughout treatment